Budget Impact Analysis of Vibegron for the Treatment of Overactive Bladder in the USA

BACKGROUND: Overactive bladder (OAB) is associated with considerable clinical and economic burden. Treatment of patients with OAB using anticholinergics is limited by tolerability issues and increased anticholinergic burden, which is associated with increased risk of dementia and falls/fractures. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jing Voon, Gahn, James C., Nesheim, Jeffrey, Mudd,, Paul N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522665/
https://www.ncbi.nlm.nih.gov/pubmed/35881325
http://dx.doi.org/10.1007/s40273-022-01163-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522665/
https://www.ncbi.nlm.nih.gov/pubmed/35881325
http://dx.doi.org/10.1007/s40273-022-01163-5

Ejemplares similares